Kennedy Investment Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$357K Sell
2,782
-45
-2% -$5.27K 0.12% 114
2026
Q1
$340K Sell
2,827
-394
-12% -$45.5K 0.13% 109
2025
Q4
$339K Sell
3,221
-195
-6% -$18.3K 0.13% 108
2025
Q3
$287K Sell
3,416
-154
-4% -$12.7K 0.11% 115
2025
Q2
$283K Sell
3,570
-440
-11% -$35K 0.12% 115
2025
Q1
$360K Buy
4,010
+170
+4% +$15.9K 0.17% 100
2024
Q4
$382K Sell
3,840
-217
-5% -$22.4K 0.17% 96
2024
Q3
$461K Buy
4,057
+590
+17% +$70.1K 0.21% 89
2024
Q2
$429K Buy
3,467
+365
+12% +$47K 0.22% 89
2024
Q1
$409K Buy
3,102
+538
+21% +$66.3K 0.22% 89
2023
Q4
$280K Buy
2,564
+354
+16% +$36.7K 0.16% 99
2023
Q3
$227K Buy
2,210
+13
+0.6% +$1.4K 0.14% 102
2023
Q2
$253K Buy
2,197
+35
+2% +$3.97K 0.15% 100
2023
Q1
$230K Sell
2,162
-2
-0.1% -$216 0.14% 104
2022
Q4
$240K Buy
+2,164
New +$221K 0.15% 103

Other funds holding MRK

Kennedy Investment Group's MRK Position: Q2 2026 in Review

Kennedy Investment Group reduced its Merck (MRK) stake by 1.6% in Q2 2026, selling an estimated $5.27K and leaving 2,782 shares worth $357K. The position accounts for 0.12% of the portfolio, ranked #114.

Kennedy Investment Group first reported a position in MRK in Q4 2022 and has held it in 15 quarters since. The position peaked at $461K in Q3 2024. 1,752 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Kennedy Investment Group held 2,782 shares of Merck worth $357K as of Q2 2026.
  • Kennedy Investment Group sold 45 Merck shares in Q2 2026, an estimated $5.27K.
  • Merck made up 0.12% of Kennedy Investment Group's portfolio in Q2 2026, its #114 holding.
  • Kennedy Investment Group first reported a position in Merck in Q4 2022 and has held it in 15 quarters since.
  • Kennedy Investment Group's Merck position peaked at $461K in Q3 2024.
  • 1,752 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Kennedy Investment Group's 13F filing for Q2 2026, filed 30 Jul 2026.